VSee Health, Inc. (VSEE) Operating Margin
- Operating margin · 12 months: Value -68.56%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -68.56% | Operating income / revenue. Period ending 2026-06-30. $-10.84M ÷ $15.81M × 100 ≈ -68.56% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -10.84M USD | Operating Income (Loss) |
| Revenue | 15.81M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
| Research and development | (m) | |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-10.84M | $15.81M | (m) | (m) | (m) | -68.56% |
| 2026-03-31 | $-10.73M | $14.46M | (m) | (m) | (m) | -74.19% |
| 2025-12-31 | $-9.58M | $14.62M | (m) | (m) | (m) | -65.55% |
| 2025-09-30 | $-9.17M | $14.43M | (m) | (m) | (m) | -63.57% |
| 2025-06-30 | $-65.41M | $13.80M | (m) | (m) | (m) | -473.96% |
| 2025-03-31 | $-64.09M | $12.12M | (m) | (m) | (m) | -528.68% |
| 2024-12-31 | $-62.15M | $10.42M | (m) | (m) | (m) | -596.38% |
| 2024-09-30 | $-59.28M | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $-2.49M | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $-2.56M | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $-2.59M | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $-2.87M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $-3.48M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $-3.76M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $-3.59M | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |